(INN) Summit Hotel Properties - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8660821005
Stock: Hotels, Guestrooms, Upscale, Portfolio, Assets
Total Rating 29
Risk 88
Buy Signal -0.17
| Risk 5d forecast | |
|---|---|
| Volatility | 33.7% |
| Relative Tail Risk | -8.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.42 |
| Alpha | -43.64 |
| Character TTM | |
|---|---|
| Beta | 1.189 |
| Beta Downside | 1.628 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.29% |
| CAGR/Max DD | -0.19 |
EPS (Earnings per Share)
Revenue
Description: INN Summit Hotel Properties March 02, 2026
Summit Hotel Properties, Inc. (NYSE: INN) is a REIT that owns and operates premium-branded upscale hotels across the United States. As of November 4 2025, its portfolio comprised 95 assets-52 wholly owned-offering 14,347 guestrooms in 24 states.
Recent data shows the company’s average occupancy rose to 71.4% in Q4 2025, up from 66.2% a year earlier, while RevPAR increased 9% year-over-year to $112. The broader upscale lodging segment is benefiting from a 4.2% annual growth in discretionary travel spend and a gradual easing of inflationary pressure on hotel operating costs.
For a deeper dive into INN’s valuation metrics, consider exploring ValueRay’s analyst tools.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: -5.63m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.13 > 1.0 |
| NWC/Revenue: 368.3% < 20% (prev -30.79%; Δ 399.0% < -1%) |
| CFO/TA 0.05 > 3% & CFO 149.0m > Net Income -5.63m |
| Net Debt (1.41b) to EBITDA (319.0m): 4.41 < 3 |
| Current Ratio: 357.4 > 1.5 & < 3 |
| Outstanding Shares: last quarter (106.8m) vs 12m ago -0.17% < -2% |
| Gross Margin: 27.85% > 18% (prev 0.35%; Δ 2749 % > 0.5%) |
| Asset Turnover: 25.72% > 50% (prev 25.27%; Δ 0.45% > 0%) |
| Interest Coverage Ratio: 0.92 > 6 (EBITDA TTM 319.0m / Interest Expense TTM 143.0m) |
Altman Z'' 5.90
| A: 0.97 (Total Current Assets 2.69b - Total Current Liabilities 7.54m) / Total Assets 2.78b |
| B: -0.15 (Retained Earnings -405.6m / Total Assets 2.78b) |
| C: 0.05 (EBIT TTM 132.1m / Avg Total Assets 2.84b) |
| D: -0.27 (Book Value of Equity -402.4m / Total Liabilities 1.50b) |
| Altman-Z'' Score: 5.90 = AAA |
Beneish M -3.52
| DSRI: 0.88 (Receivables 17.3m/19.8m, Revenue 729.5m/731.8m) |
| GMI: 1.27 (GM 27.85% / 35.48%) |
| AQI: 0.02 (AQ_t 0.02 / AQ_t-1 0.96) |
| SGI: 1.00 (Revenue 729.5m / 731.8m) |
| TATA: -0.06 (NI -5.63m - CFO 149.0m) / TA 2.78b) |
| Beneish M-Score: -3.52 (Cap -4..+1) = AAA |
What is the price of INN shares?
As of March 07, 2026, the stock is trading at USD 4.71 with a total of 593,994 shares traded.
Over the past week, the price has changed by +1.29%, over one month by +9.18%, over three months by -2.38% and over the past year by -23.04%.
Over the past week, the price has changed by +1.29%, over one month by +9.18%, over three months by -2.38% and over the past year by -23.04%.
Is INN a buy, sell or hold?
Summit Hotel Properties has received a consensus analysts rating of 3.50.
Therefor, it is recommend to hold INN.
- StrongBuy: 1
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the INN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5.6 | 19.5% |
| Analysts Target Price | 5.6 | 19.5% |
INN Fundamental Data Overview March 04, 2026
P/S = 0.6906
P/B = 0.5753
Revenue TTM = 729.5m USD
EBIT TTM = 132.1m USD
EBITDA TTM = 319.0m USD
Long Term Debt = 1.42b USD (from longTermDebt, two quarters ago)
Short Term Debt = 449.0m USD (from shortTermDebt, last quarter)
Debt = 1.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.41b USD (from netDebt column, last quarter)
Enterprise Value = -730.5m USD (503.8m + Debt 1.44b - CCE 2.68b)
Interest Coverage Ratio = 0.92 (Ebit TTM 132.1m / Interest Expense TTM 143.0m)
EV/FCF = -5.62x (Enterprise Value -730.5m / FCF TTM 129.9m)
FCF Yield = -17.79% (FCF TTM 129.9m / Enterprise Value -730.5m)
FCF Margin = 17.81% (FCF TTM 129.9m / Revenue TTM 729.5m)
Net Margin = -0.77% (Net Income TTM -5.63m / Revenue TTM 729.5m)
Gross Margin = 27.85% ((Revenue TTM 729.5m - Cost of Revenue TTM 526.3m) / Revenue TTM)
Gross Margin QoQ = 8.62% (prev 30.56%)
Tobins Q-Ratio = -0.26 (set to none) (Enterprise Value -730.5m / Total Assets 2.78b)
Interest Expense / Debt = 5.66% (Interest Expense 81.7m / Debt 1.44b)
Taxrate = 21.0% (US default 21%)
NOPAT = 104.4m (EBIT 132.1m * (1 - 21.00%))
Current Ratio = 357.4 (out of range, set to none) (Total Current Assets 2.69b / Total Current Liabilities 7.54m)
Debt / Equity = 1.67 (Debt 1.44b / totalStockholderEquity, last quarter 862.2m)
Debt / EBITDA = 4.41 (Net Debt 1.41b / EBITDA 319.0m)
Debt / FCF = 10.82 (Net Debt 1.41b / FCF TTM 129.9m)
Total Stockholder Equity = 888.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.20% (Net Income -5.63m / Total Assets 2.78b)
RoE = -0.63% (Net Income TTM -5.63m / Total Stockholder Equity 888.4m)
RoCE = 5.72% (EBIT 132.1m / Capital Employed (Equity 888.4m + L.T.Debt 1.42b))
RoIC = 4.50% (NOPAT 104.4m / Invested Capital 2.32b)
WACC = 5.93% (E(503.8m)/V(1.95b) * Re(10.10%) + D(1.44b)/V(1.95b) * Rd(5.66%) * (1-Tc(0.21)))
Discount Rate = 10.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.56%
[DCF] Terminal Value 86.52% ; FCFF base≈133.7m ; Y1≈138.1m ; Y5≈155.8m
[DCF] Fair Price = 29.20 (EV 4.58b - Net Debt 1.41b = Equity 3.18b / Shares 108.8m; r=5.93% [WACC]; 5y FCF grow 3.30% → 2.90% )
EPS Correlation: -4.40 | EPS CAGR: 25.56% | SUE: 0.45 | # QB: 0
Revenue Correlation: 34.44 | Revenue CAGR: 5.75% | SUE: 0.89 | # QB: 1
EPS next Quarter (2026-06-30): EPS=-0.07 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=-0.50 | Chg7d=-0.050 | Chg30d=-0.050 | Revisions Net=-1 | Growth EPS=-127.3% | Growth Revenue=+2.1%
EPS next Year (2027-12-31): EPS=-0.51 | Chg7d=-0.510 | Chg30d=-0.510 | Revisions Net=+0 | Growth EPS=+0.0% | Growth Revenue=+2.0%
P/B = 0.5753
Revenue TTM = 729.5m USD
EBIT TTM = 132.1m USD
EBITDA TTM = 319.0m USD
Long Term Debt = 1.42b USD (from longTermDebt, two quarters ago)
Short Term Debt = 449.0m USD (from shortTermDebt, last quarter)
Debt = 1.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.41b USD (from netDebt column, last quarter)
Enterprise Value = -730.5m USD (503.8m + Debt 1.44b - CCE 2.68b)
Interest Coverage Ratio = 0.92 (Ebit TTM 132.1m / Interest Expense TTM 143.0m)
EV/FCF = -5.62x (Enterprise Value -730.5m / FCF TTM 129.9m)
FCF Yield = -17.79% (FCF TTM 129.9m / Enterprise Value -730.5m)
FCF Margin = 17.81% (FCF TTM 129.9m / Revenue TTM 729.5m)
Net Margin = -0.77% (Net Income TTM -5.63m / Revenue TTM 729.5m)
Gross Margin = 27.85% ((Revenue TTM 729.5m - Cost of Revenue TTM 526.3m) / Revenue TTM)
Gross Margin QoQ = 8.62% (prev 30.56%)
Tobins Q-Ratio = -0.26 (set to none) (Enterprise Value -730.5m / Total Assets 2.78b)
Interest Expense / Debt = 5.66% (Interest Expense 81.7m / Debt 1.44b)
Taxrate = 21.0% (US default 21%)
NOPAT = 104.4m (EBIT 132.1m * (1 - 21.00%))
Current Ratio = 357.4 (out of range, set to none) (Total Current Assets 2.69b / Total Current Liabilities 7.54m)
Debt / Equity = 1.67 (Debt 1.44b / totalStockholderEquity, last quarter 862.2m)
Debt / EBITDA = 4.41 (Net Debt 1.41b / EBITDA 319.0m)
Debt / FCF = 10.82 (Net Debt 1.41b / FCF TTM 129.9m)
Total Stockholder Equity = 888.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.20% (Net Income -5.63m / Total Assets 2.78b)
RoE = -0.63% (Net Income TTM -5.63m / Total Stockholder Equity 888.4m)
RoCE = 5.72% (EBIT 132.1m / Capital Employed (Equity 888.4m + L.T.Debt 1.42b))
RoIC = 4.50% (NOPAT 104.4m / Invested Capital 2.32b)
WACC = 5.93% (E(503.8m)/V(1.95b) * Re(10.10%) + D(1.44b)/V(1.95b) * Rd(5.66%) * (1-Tc(0.21)))
Discount Rate = 10.10% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.56%
[DCF] Terminal Value 86.52% ; FCFF base≈133.7m ; Y1≈138.1m ; Y5≈155.8m
[DCF] Fair Price = 29.20 (EV 4.58b - Net Debt 1.41b = Equity 3.18b / Shares 108.8m; r=5.93% [WACC]; 5y FCF grow 3.30% → 2.90% )
EPS Correlation: -4.40 | EPS CAGR: 25.56% | SUE: 0.45 | # QB: 0
Revenue Correlation: 34.44 | Revenue CAGR: 5.75% | SUE: 0.89 | # QB: 1
EPS next Quarter (2026-06-30): EPS=-0.07 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=-0.50 | Chg7d=-0.050 | Chg30d=-0.050 | Revisions Net=-1 | Growth EPS=-127.3% | Growth Revenue=+2.1%
EPS next Year (2027-12-31): EPS=-0.51 | Chg7d=-0.510 | Chg30d=-0.510 | Revisions Net=+0 | Growth EPS=+0.0% | Growth Revenue=+2.0%